Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry.

J Interv Card Electrophysiol 2019 Apr 19. Epub 2019 Apr 19.

Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Diego, San Diego, CA, USA.

Background: Cardiac resynchronization therapy with defibrillator (CRT-D) implantation involves left ventricular (LV) lead placement for biventricular pacing and is more complex than implantable cardioverter-defibrillator (ICD)-only implantation. Differences in the prescription of CRT-D versus ICD may result from clinician biases based on patient body habitus, and body habitus may be associated with LV lead implantation failure.

Objective: We sought to evaluate whether patient body mass index (BMI) was associated with planned use and implantation failure of CRT-D therapy.

Methods: We studied all patients enrolled in the National Cardiovascular Data Registry ICD Registry who met standard CRT-D criteria and received either an ICD or CRT-D between 2010 and 2012. BMI was categorized based on World Health Organization classification. Using hierarchical logistic regression, two multivariate models adjusted for patient demographic and clinical characteristics were fit based on the following outcome variables: (1) planned implantation with CRT-D versus ICD and (2) failed versus successful LV lead placement.

Results: Of 337,547 patients, 41,872 met inclusion criteria for the first analysis and 35,186 met criteria for the second analysis. After multivariable adjustment, patients with extreme (BMI > 40 kg/m) obesity were less likely to receive guideline-concordant CRT-D compared with patients with normal weight (adjusted odds ratio (AOR), 0.86; 95% confidence interval (CI), 0.75-0.99; p = 0.04). Extreme (BMI > 40 kg/m) obesity was associated with higher odds of failed LV lead placement (AOR, 1.35; 95% CI, 1.07-1.72, p = 0.01).

Conclusions: Compared with normal weight patients, extremely obese (BMI > 40 kg/m) CRT-D eligible patients were less likely to be prescribed CRT-D and were at higher odds for failed LV lead placement.

Download full-text PDF

Source Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2019
2 Reads

Publication Analysis

Top Keywords

lead placement
bmi > 40 kg/m
planned implantation
normal weight
lead implantation
implantation failure
failed lead
higher odds
versus icd
crt-d versus
patient body
body habitus
ventricular lead
odds failed
implantable cardioverter-defibrillator
extreme bmi
cardiac resynchronization
body mass
resynchronization therapy


(Supplied by CrossRef)
Article in N Engl J Med
WT Abraham et al.
N Engl J Med 2002
Article in N Engl J Med
MR Bristow et al.
N Engl J Med 2004
Article in N Engl J Med
JGF Cleland et al.
N Engl J Med 2005
Article in N Engl J Med
AJ Moss et al.
N Engl J Med 2009
Article in Circ Arrhythm Electrophysiol
V Essebag et al.
Circ Arrhythm Electrophysiol 2015
Article in J Am Coll Cardiol
CM Tracy et al.
J Am Coll Cardiol 2013
Article in Circulation
AE Epstein et al.
Circulation 2008
Article in Europace
M Fatemi et al.
Europace 2008
Article in Pacing Clin Electrophysiol
J Kautzner et al.
Pacing Clin Electrophysiol 2004
Article in Europace
D Gras et al.
Europace 2007
Article in J Cardiovasc Electrophysiol
EG Daoud et al.
J Cardiovasc Electrophysiol 2002

Similar Publications